Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01113905 · ClinicalTrials.gov registry record
Role of Beta-Endorphin in Cancer Therapy Fatigue
A clinical trial, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- 18
- Enrollment target
NCT01113905: Clinical Trial study, sponsored by Massachusetts General Hospital.
NCT01113905 is a clinical trial that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01113905 was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The investigators aim to test whether beta-endorphin, a substance our bodies make in response to painful and stressful stimuli, plays a causative role in radiation-induced fatigue that cancer patients receiving radiation therapy commonly experience. If this is so, the investigators' hope is to direct efforts at treating radiation-induced fatigue using agents that block the action of beta-endorphin with the aim of improving quality of life for patients undergoing radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2009-12 |
| Est. Completion | 2014-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01113905
The ClinicalTrials.gov registry entry for NCT01113905 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01113905 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01113905 about?
NCT01113905 is a clinical study titled "Role of Beta-Endorphin in Cancer Therapy Fatigue". The investigators aim to test whether beta-endorphin, a substance our bodies make in response to painful and stressful stimuli, plays a causative role in radiation-induced fatigue that cancer patients receiving radiation therapy commonly experience. If this is so, the investigators' hope is to direc...
What is the current status of trial NCT01113905?
This trial is currently terminated. The enrollment target is 18 participants. The study started on 2009-12. Estimated completion is 2014-08.
Who is sponsoring clinical trial NCT01113905?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.